American Journal of Epidemiology Vol. 154, No. 5 : 451-458
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
Risk Assessment for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) based on an Epidemiologic Study
1 From the Robert A. Taft Laboratories, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH.
The International Agency for Research on Cancer (Lyon, France) recently concluded that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a human carcinogen. There have been few human studies and risk assessments with quantitative exposure data. The authors previously conducted exposure-response analyses based on estimated external TCDD exposure for 3,538 US male chemical workers and found a positive trend for all cancer with increasing cumulative exposure. In the present study, 1988 data from 170 workers with both estimated external exposure and known serum TCDD levels were used to derive the relation between the two. This derived relation was used to estimate serum TCDD levels over time for all 3,538 workers, and new dose-response analyses were conducted by using cumulative serum level. A positive trend (p = 0.003) was found between estimated log cumulative TCDD serum level and cancer mortality. For males, the excess lifetime (75 years) risk of dying of cancer given a TCDD intake of 1.0 pg/kg of body weight per day, twice the background intake, was an estimated 0.05–0.9% above a background lifetime risk of cancer death of 12.4%. Data from this cohort are consistent with another epidemiologic risk assessment from Germany and support recent conclusions by the US Environmental Protection Agency.
carcinogens; dioxins; risk assessment
Abbreviations: TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; TEQ, toxic equivalent.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. J. Walker, K. Yoshizawa, R. A. Miller, A. E. Brix, D. M. Sells, M. P. Jokinen, M. E. Wyde, M. Easterling, and A. Nyska Pulmonary Lesions in Female Harlan Sprague-Dawley Rats Following Two-Year Oral Treatment with Dioxin-Like Compounds Toxicol Pathol, December 1, 2007; 35(7): 880 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Popp, E. Crouch, and E. E. McConnell A Weight-of-Evidence Analysis of the Cancer Dose-Response Characteristics of 2,3,7,8-Tetrachlorodibenzodioxin (TCDD) Toxicol. Sci., February 1, 2006; 89(2): 361 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yoshizawa, T. Marsh, J. F. Foley, B. Cai, S. Peddada, N. J. Walker, and A. Nyska Mechanisms of Exocrine Pancreatic Toxicity Induced by Oral Treatment with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Female Harlan Sprague-Dawley Rats Toxicol. Sci., May 1, 2005; 85(1): 594 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A 't Mannetje, D McLean, S Cheng, P Boffetta, D Colin, and N Pearce Mortality in New Zealand workers exposed to phenoxy herbicides and dioxins Occup. Environ. Med., January 1, 2005; 62(1): 34 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yoshizawa, N. J. Walker, M. P. Jokinen, A. E. Brix, D. M. Sells, T. Marsh, M. E. Wyde, D. Orzech, J. K. Haseman, and A. Nyska Gingival Carcinogenicity in Female Harlan Sprague-Dawley Rats following Two-Year Oral Treatment with 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Dioxin-Like Compounds Toxicol. Sci., January 1, 2005; 83(1): 64 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Steenland, L Stayner, and J Deddens Mortality analyses in a cohort of 18 235 ethylene oxide exposed workers: follow up extended from 1987 to 1998 Occup. Environ. Med., January 1, 2004; 61(1): 2 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsuda, A. Naito, C. K. Kim, K. Fukamachi, H. Nomoto, and M. A. Moore Carcinogenesis and Its Modification by Environmental Endocrine Disruptors: In Vivo Experimental and Epidemiological Findings Jpn. J. Clin. Oncol., June 1, 2003; 33(6): 259 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 RE: "RISK ASSESSMENT FOR 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) BASED ON AN EPIDEMIOLOGIC STUDY" Am. J. Epidemiol., January 15, 2002; 155(2): 189 - 189. [Full Text] [PDF]
|
|